Physician profile
David M Sayah
NPI 1023288719
$63,962.59
in general payments reported to CMS, 2019-2025
9 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $162 · 2021: $35.56 · 2022: $19K · 2023: $24K · 2024: $20K · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $16K · Consulting Fee: $9,100 · Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,811.25 |
| Travel and Lodging | $16,100.76 |
| Consulting Fee | $9,100.00 |
| Food and Beverage | $571.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $41,267.38 | 2022-2024 | Livtencity |
| Mallinckrodt Hospital Products INC. | $21,923.19 | 2023-2024 | Cellex, Uvadex |
| Tepha INC | $379.31 | 2019-2020 | |
| Abiomed | $125.25 | 2025 | |
| Grifols USA, LLC | $125.00 | 2019 | |
| Allergan, INC. | $90.66 | 2020-2022 | |
| United Therapeutics Corporation | $19.05 | 2021 | |
| Genentech USA, INC. | $16.51 | 2021 | |
| Insmed, INC. | $16.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sayah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.